Marc Peeters Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON) University of Antwerp Biography Publications Institution JoVE Articles Marc Peeters has not added a biography. If you are Marc Peeters and would like to personalize this page please email our Author Liaison for assistance. Publications Methylation Biomarkers for Early Cancer Detection and Diagnosis: Current and Future Perspectives European Journal of Cancer (Oxford, England : 1990). Jan, 2023 | Pubmed ID: 36427394 Boosting Capacity of a Fourth Dose BNT162b2 in Cancer Patients European Journal of Cancer (Oxford, England : 1990). Nov, 2022 | Pubmed ID: 36521333 Humoral and Cellular Immune Responses Against SARS-CoV-2 After Third Dose BNT162b2 Following Double-dose Vaccination with BNT162b2 Versus ChAdOx1 in Cancer Patients Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2022 | Pubmed ID: 36341493 Point Scintillator Dosimetry in Ultra-high Dose Rate Electron "FLASH" Radiation Therapy: A First Characterization Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB). Nov, 2022 | Pubmed ID: 36302279 The Prognostic Impact of the Immune Signature in Head and Neck Squamous Cell Carcinoma Frontiers in Immunology. 2022 | Pubmed ID: 36268020 Increasing Adherence to Prophylactic Swallowing Exercises During Head and Neck Radiotherapy: The Multicenter, Randomized Controlled PRESTO-Trial Dysphagia. Sep, 2022 | Pubmed ID: 36121560 Prognostic Implications of Cellular Senescence in Resected Non-small Cell Lung Cancer Translational Lung Cancer Research. Aug, 2022 | Pubmed ID: 36090630 Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy Cancers. Aug, 2022 | Pubmed ID: 36077610 Epidemiology of Spinal Metastases, Metastatic Epidural Spinal Cord Compression and Pathologic Vertebral Compression Fractures in Patients with Solid Tumors: A Systematic Review Journal of Bone Oncology. Aug, 2022 | Pubmed ID: 35860387 Ipilimumab- and Nivolumab-induced Myocarditis in a Patient with Metastatic Cholangiocarcinoma: a Case Report Journal of Medical Case Reports. Jul, 2022 | Pubmed ID: 35831829 Comparison of S1 Antibody Titers Between BNT162b2 and ChAdOx1 COVID-19 Vaccination in Cancer Patients ESMO Open. Apr, 2022 | Pubmed ID: 35305399 Targeting Hedgehog Signaling in Pancreatic Ductal Adenocarcinoma Pharmacology & Therapeutics. Aug, 2022 | Pubmed ID: 34999181 Reduced Humoral Immune Response After BNT162b2 Coronavirus Disease 2019 Messenger RNA Vaccination in Cancer Patients Under Antineoplastic Treatment ESMO Open. Oct, 2021 | Pubmed ID: 34597941 Prescreening for COVID-19 in Patients Receiving Cancer Treatment Using a Patient-reported Outcome Platform ESMO Open. Jun, 2020 | Pubmed ID: 32571785 Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells Cancers. Oct, 2019 | Pubmed ID: 31635070 RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review International Journal of Molecular Sciences. May, 2019 | Pubmed ID: 31052546 Circulating Cell-Free DNA and RNA Analysis As Liquid Biopsy: Optimal Centrifugation Protocol Cancers. Mar, 2019 | Pubmed ID: 30935089 Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib Cancers. Jan, 2019 | Pubmed ID: 30650638 Relationships Between Tumour Response and Primary Tumour Location, and Predictors of Long-term Survival, in Patients with RAS Wild-type Metastatic Colorectal Cancer Receiving First-line Panitumumab Therapy: Retrospective Analyses of the PRIME and PEAK Clinical Trials British Journal of Cancer. Aug, 2018 | Pubmed ID: 30013091 Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant P53 and Can Be Overcome by Induction of Oxidative Stress Cancers. Apr, 2018 | Pubmed ID: 29690507 Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies Clinical Colorectal Cancer. Sep, 2018 | Pubmed ID: 29627309 Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients Clinical Colorectal Cancer. Jun, 2018 | Pubmed ID: 29605591 The Predictive Value of Primary Tumor Location in Patients with Metastatic Colorectal Cancer: A Systematic Review Critical Reviews in Oncology/hematology. Jan, 2018 | Pubmed ID: 29279095 Validity and Reproducibility of a Food Frequency Questionnaire for Dietary Factors Related to Colorectal Cancer Nutrients. Nov, 2017 | Pubmed ID: 29149033 Targeting Angiogenesis in Biliary Tract Cancers: An Open Option International Journal of Molecular Sciences. Feb, 2017 | Pubmed ID: 28212293 Feasibility of an Interactive Electronic Self-report Tool for Oral Cancer Therapy in an Outpatient Setting Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. Mar, 2016 | Pubmed ID: 27025594 Evaluation and Consequences of Heterogeneity in the Circulating Tumor Cell Compartment Oncotarget. Mar, 2016 | Pubmed ID: 26980749 Long-term Acquired Everolimus Resistance in Pancreatic Neuroendocrine Tumours Can Be Overcome with Novel PI3K-AKT-mTOR Inhibitors British Journal of Cancer. Mar, 2016 | Pubmed ID: 26978006 APR-246 (PRIMA-1(MET)) Strongly Synergizes with AZD2281 (olaparib) Induced PARP Inhibition to Induce Apoptosis in Non-small Cell Lung Cancer Cell Lines Cancer Letters. Jun, 2016 | Pubmed ID: 26975633 Exosomes Isolation and Characterization in Serum is Feasible in Non-small Cell Lung Cancer Patients: Critical Analysis of Evidence and Potential Role in Clinical Practice Oncotarget. Feb, 2016 | Pubmed ID: 26919248 SIRFLOX: Randomized Phase III Trial Comparing First-Line MFOLFOX6 (Plus or Minus Bevacizumab) Versus MFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2016 | Pubmed ID: 26903575 Reducing Compounds Equivocally Influence Oxidation During Digestion of a High-Fat Beef Product, Which Promotes Cytotoxicity in Colorectal Carcinoma Cell Lines Journal of Agricultural and Food Chemistry. Feb, 2016 | Pubmed ID: 26836477 Long-acting Octreotide As Secondary Prevention of Chemotherapy-induced Diarrhea: Proof of Concept Minerva Chirurgica. Jan, 2016 | Pubmed ID: 26771252 Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis The Oncologist. Jan, 2016 | Pubmed ID: 26712958 Entrectinib: a Potent New TRK, ROS1, and ALK Inhibitor Expert Opinion on Investigational Drugs. 2015 | Pubmed ID: 26457764 The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer PloS One. 2015 | Pubmed ID: 26421426 A Phase I Study of Volasertib Combined with Afatinib, in Advanced Solid Tumors Cancer Chemotherapy and Pharmacology. Oct, 2015 | Pubmed ID: 26349473 Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2 Drugs. Oct, 2015 | Pubmed ID: 26347132 Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone As Second-line Treatment for Metastatic Colorectal Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2015 | Pubmed ID: 26341920 Next Generation Exome Sequencing of Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1 Reveals Different Lineages Cancer Genetics. Oct, 2015 | Pubmed ID: 26341699 Study Protocol for a Randomized Controlled Trial: Tongue Strengthening Exercises in Head and Neck Cancer Patients, Does Exercise Load Matter? Trials. 2015 | Pubmed ID: 26340887 New Findings on Primary and Acquired Resistance to Anti-EGFR Therapy in Metastatic Colorectal Cancer: Do All Roads Lead to RAS? Oncotarget. Sep, 2015 | Pubmed ID: 26318427 Establishment and Characterization of Cetuximab Resistant Head and Neck Squamous Cell Carcinoma Cell Lines: Focus on the Contribution of the AP-1 Transcription Factor American Journal of Cancer Research. 2015 | Pubmed ID: 26269754 The MDM2-inhibitor Nutlin-3 Synergizes with Cisplatin to Induce P53 Dependent Tumor Cell Apoptosis in Non-small Cell Lung Cancer Oncotarget. Sep, 2015 | Pubmed ID: 26125230 Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward Gastroenterology Research and Practice. 2015 | Pubmed ID: 26101524 Prevalence of RAS Mutations and Individual Variation Patterns Among Patients with Metastatic Colorectal Cancer: A Pooled Analysis of Randomised Controlled Trials European Journal of Cancer (Oxford, England : 1990). Sep, 2015 | Pubmed ID: 26049686 The Hypoxic Tumor Microenvironment and Drug Resistance Against EGFR Inhibitors: Preclinical Study in Cetuximab-sensitive Head and Neck Squamous Cell Carcinoma Cell Lines BMC Research Notes. 2015 | Pubmed ID: 26032726 Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer The New England Journal of Medicine. May, 2015 | Pubmed ID: 25970050 Impact of Early Tumour Shrinkage and Resection on Outcomes in Patients with Wild-type RAS Metastatic Colorectal Cancer European Journal of Cancer (Oxford, England : 1990). Jul, 2015 | Pubmed ID: 25956209 Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status Drugs. May, 2015 | Pubmed ID: 25895463 Erratum: Preoperative Chemosensitivity Testing As Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer (PePiTA): Protocol of a Prospective BGDO (Belgian Group for Digestive Oncology) Multicentric Study BMC Cancer. 2015 | Pubmed ID: 25879441 Engineering Monocyte-derived Dendritic Cells to Secrete Interferon-α Enhances Their Ability to Promote Adaptive and Innate Anti-tumor Immune Effector Functions Cancer Immunology, Immunotherapy : CII. Jul, 2015 | Pubmed ID: 25863943 Incorporating Anti-VEGF Pathway Therapy As a Continuum of Care in Metastatic Colorectal Cancer Current Treatment Options in Oncology. Apr, 2015 | Pubmed ID: 25813037 Whole-exome Characterization of Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1 Journal of Molecular Endocrinology. Apr, 2015 | Pubmed ID: 25612765 Cancer and the Microbiome: Potential Applications As New Tumor Biomarker Expert Review of Anticancer Therapy. Mar, 2015 | Pubmed ID: 25495037 Circulating Tumour Cells and Lung Microvascular Tumour Cell Retention in Patients with Metastatic Breast and Cervical Cancer Cancer Letters. Jan, 2015 | Pubmed ID: 25449778 Expression Profiling of Migrated and Invaded Breast Cancer Cells Predicts Early Metastatic Relapse and Reveals Krüppel-like Factor 9 As a Potential Suppressor of Invasive Growth in Breast Cancer Oncoscience. 2014 | Pubmed ID: 25593984 Case Histories in Unresectable Liver-dominant Metastatic Colorectal Cancer Future Oncology (London, England). Nov, 2014 | Pubmed ID: 25478766 FOLFIRI with Cetuximab or Bevacizumab: FIRE-3 The Lancet. Oncology. Dec, 2014 | Pubmed ID: 25456374 Liquid Biopsies in Lung Cancer: the New Ambrosia of Researchers Biochimica Et Biophysica Acta. Dec, 2014 | Pubmed ID: 25444714 Overcoming Cetuximab Resistance in HNSCC: the Role of AURKB and DUSP Proteins Cancer Letters. Nov, 2014 | Pubmed ID: 25192874 The Radiosensitising Effect of Gemcitabine and Its Main Metabolite DFdU Under Low Oxygen Conditions is in Vitro Not Dependent on Functional HIF-1 Protein BMC Cancer. 2014 | Pubmed ID: 25128202 Use of Antiemetics in the Prevention of Chemotherapy-induced Nausea and Vomiting: Review and Focus on the Belgian Situation Acta Gastro-enterologica Belgica. Jun, 2014 | Pubmed ID: 25090823 ASPECCT: Panitumumab Versus Cetuximab for Colorectal Cancer--authors' Reply The Lancet. Oncology. Jul, 2014 | Pubmed ID: 24988928 The Role of Targeted Therapy for Gastrointestinal Tumors Expert Review of Gastroenterology & Hepatology. Nov, 2014 | Pubmed ID: 24957206 Novel Therapeutic Strategies for Patients with NSCLC That Do Not Respond to Treatment with EGFR Inhibitors Cancer Treatment Reviews. Sep, 2014 | Pubmed ID: 24953979 Mutation Analysis of Genes in the EGFR Pathway in Head and Neck Cancer Patients: Implications for Anti-EGFR Treatment Response BMC Research Notes. 2014 | Pubmed ID: 24899223 Panitumumab Versus Cetuximab in Patients with Chemotherapy-refractory Wild-type KRAS Exon 2 Metastatic Colorectal Cancer (ASPECCT): a Randomised, Multicentre, Open-label, Non-inferiority Phase 3 Study The Lancet. Oncology. May, 2014 | Pubmed ID: 24739896 How to Find the Ariadne's Thread in the Labyrinth of Salvage Treatment Options for Metastatic Colorectal Cancer? Expert Opinion on Biological Therapy. Jun, 2014 | Pubmed ID: 24673103 Antineoplastic Therapy-induced Pulmonary Toxicity Expert Review of Anticancer Therapy. Aug, 2013 | Pubmed ID: 23984900 Dilemma in Metastatic Colorectal Cancer: VEGF Versus EGRF Targeting Expert Opinion on Therapeutic Targets. Aug, 2013 | Pubmed ID: 23848525 Anti-epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance The Oncologist. 2013 | Pubmed ID: 23821327 An Analysis of the Treatment Effect of Panitumumab on Overall Survival from a Phase 3, Randomized, Controlled, Multicenter Trial (20020408) in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Targeted Oncology. Jun, 2013 | Pubmed ID: 23625191 Preoperative Chemosensitivity Testing As Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer (PePiTA): Protocol of a Prospective BGDO (Belgian Group for Digestive Oncology) Multicentric Study BMC Cancer. 2013 | Pubmed ID: 23587148 Expression Analysis on Archival Material Revisited: Isolation and Quantification of RNA Extracted from FFPE Samples Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. Mar, 2013 | Pubmed ID: 23370428 Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2013 | Pubmed ID: 23325582 Mutant KRAS Codon 12 and 13 Alleles in Patients with Metastatic Colorectal Cancer: Assessment As Prognostic and Predictive Biomarkers of Response to Panitumumab Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2013 | Pubmed ID: 23182985 The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors Current Pharmaceutical Design. 2013 | Pubmed ID: 22973959 Probiotics Enhance the Clearance of Human Papillomavirus-related Cervical Lesions: a Prospective Controlled Pilot Study European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP). Jan, 2013 | Pubmed ID: 22706167 Clinical Procedure for Colon Carcinoma Tissue Sampling Directly Affects the Cancer Marker-capacity of VEGF Family Members BMC Cancer. 2012 | Pubmed ID: 23148666 Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-time Technology and Classic Endpoint Assays PloS One. 2012 | Pubmed ID: 23094027 Will the Medical Student in the Team Please Stand Up? The Lancet. Oncology. Aug, 2012 | Pubmed ID: 22846828 Intrapatient Cetuximab Dose Escalation in Metastatic Colorectal Cancer According to the Grade of Early Skin Reactions: the Randomized EVEREST Study Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Aug, 2012 | Pubmed ID: 22753904 Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal Cancer Annals of Surgical Oncology. Sep, 2012 | Pubmed ID: 22526897 LICC: L-BLP25 in Patients with Colorectal Carcinoma After Curative Resection of Hepatic Metastases: a Randomized, Placebo-controlled, Multicenter, Multinational, Double-blinded Phase II Trial BMC Cancer. 2012 | Pubmed ID: 22494623 Single-photon Emission Computed Tomographic Imaging of the Early Time Course of Therapy-induced Cell Death Using Technetium 99m Tricarbonyl His-annexin A5 in a Colorectal Cancer Xenograft Model Molecular Imaging. Apr, 2012 | Pubmed ID: 22469241 The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: a Belgian Multicentre Prospective Phase II Clinical Study Annals of Surgical Oncology. Jul, 2012 | Pubmed ID: 22395983 Panitumumab in Combination with Cytotoxic Chemotherapy for the Treatment of Metastatic Colorectal Carcinoma Clinical Colorectal Cancer. Mar, 2012 | Pubmed ID: 21925954 Biologic Therapies in the Metastatic Colorectal Cancer Treatment Continuum--applying Current Evidence to Clinical Practice Cancer Treatment Reviews. Aug, 2012 | Pubmed ID: 21899955 Tumor Cells and Tumor-associated Macrophages: Secreted Proteins As Potential Targets for Therapy Clinical & Developmental Immunology. 2011 | Pubmed ID: 22162712 Everolimus Plus Octreotide Long-acting Repeatable for the Treatment of Advanced Neuroendocrine Tumours Associated with Carcinoid Syndrome (RADIANT-2): a Randomised, Placebo-controlled, Phase 3 Study Lancet (London, England). Dec, 2011 | Pubmed ID: 22119496 Expression Analysis on Archival Material: Comparison of 5 Commercially Available RNA Isolation Kits for FFPE Material Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. Dec, 2011 | Pubmed ID: 22089347 (99)mTc-(CO)(3) His-annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Nov, 2011 | Pubmed ID: 22045708 Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. Dec, 2011 | Pubmed ID: 21618031 Assessment of Neovascular Permeability in a Pancreatic Tumor Model Using Dynamic Contrast-enhanced (DCE) MRI with Contrast Agents of Different Molecular Weights Magma (New York, N.Y.). Aug, 2011 | Pubmed ID: 21567161 Digestive Oncologist in the Gastroenterology Training Curriculum World Journal of Gastroenterology. Mar, 2011 | Pubmed ID: 21556128 In Vivo Imaging of Apoptosis in Oncology: an Update Molecular Imaging. Oct, 2011 | Pubmed ID: 21521554 Retention of the in Vitro Radiosensitizing Potential of Gemcitabine Under Anoxic Conditions, in P53 Wild-type and P53-deficient Non-small-cell Lung Carcinoma Cells International Journal of Radiation Oncology, Biology, Physics. Jun, 2011 | Pubmed ID: 21377279 EGFR in Melanoma: Clinical Significance and Potential Therapeutic Target Journal of Cutaneous Pathology. Jun, 2011 | Pubmed ID: 21352258 Health-related Quality of Life and Colorectal Cancer-specific Symptoms in Patients with Chemotherapy-refractory Metastatic Disease Treated with Panitumumab International Journal of Colorectal Disease. Feb, 2011 | Pubmed ID: 21190026 Noninvasive Monitoring of Therapy-induced Microvascular Changes in a Pancreatic Cancer Model Using Dynamic Contrast-enhanced Magnetic Resonance Imaging with P846, a New Low-diffusible Gadolinium-based Contrast Agent Radiation Research. Jan, 2011 | Pubmed ID: 21175342 MDM2 Gene Amplification and Protein Expressions in Colon Carcinoma: is Targeting MDM2 a New Therapeutic Option? Virchows Archiv : an International Journal of Pathology. Feb, 2011 | Pubmed ID: 21113617 The Presence of Y Chromosomal Deoxyribonucleic Acid in the Female Vaginal Swab: Possible Implications for Human Papillomavirus Testing Cancer Epidemiology. Feb, 2011 | Pubmed ID: 21095173 In Vitro and in Vivo Evaluation of [99mTc]-labeled Tricarbonyl His-annexin A5 As an Imaging Agent for the Detection of Phosphatidylserine-expressing Cells Nuclear Medicine and Biology. Nov, 2010 | Pubmed ID: 21055628 Randomized Phase III Study of Panitumumab with Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared with FOLFIRI Alone As Second-line Treatment in Patients with Metastatic Colorectal Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Nov, 2010 | Pubmed ID: 20921462 Role of Cell Cycle Perturbations in the Combination Therapy of Chemotherapeutic Agents and Radiation Future Oncology (London, England). Sep, 2010 | Pubmed ID: 20919831 Adjuvant Gemcitabine Alone Versus Gemcitabine-based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: a Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2010 | Pubmed ID: 20837948 Deoxycitidine Kinase is Associated with Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma Cancer. Nov, 2010 | Pubmed ID: 20669326 Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or with Yttrium-90 Resin Microspheres Radioembolization for Liver-limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Aug, 2010 | Pubmed ID: 20567019 Epidermal Growth Factor Receptor and K-RAS Status in Two Cohorts of Squamous Cell Carcinomas BMC Cancer. 2010 | Pubmed ID: 20459770 Psychometric Evaluation of the FACT Colorectal Cancer Symptom Index (FCSI-9): Reliability, Validity, Responsiveness, and Clinical Meaningfulness The Oncologist. 2010 | Pubmed ID: 20189976 Cardiovascular Risk Status Can Influence the Colorectal Cancer Screening Strategy Digestion. 2010 | Pubmed ID: 20029205 Combined Effect of EPO and Radiotherapy on the Expression of Endogenous Molecular Markers of Tumor Metabolism and Metastasis Cancer Biotherapy & Radiopharmaceuticals. Oct, 2009 | Pubmed ID: 19877886 Amphiregulin and Epiregulin MRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated with Cetuximab Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2009 | Pubmed ID: 19738126 Forcing Cancer Cells to Commit Suicide Cancer Biotherapy & Radiopharmaceuticals. Aug, 2009 | Pubmed ID: 19694574 Expression of Hexokinases and Glucose Transporters in Treated and Untreated Oesophageal Adenocarcinoma Histology and Histopathology. Aug, 2009 | Pubmed ID: 19554504 Antiangiogenic Versus Cytotoxic Therapeutic Approaches in a Mouse Model of Pancreatic Cancer: an Experimental Study with a Multitarget Tyrosine Kinase Inhibitor (sunitinib), Gemcitabine and Radiotherapy Oncology Reports. Jul, 2009 | Pubmed ID: 19513511 Cetuximab in Combination with Irinotecan/5-fluorouracil/folinic Acid (FOLFIRI) in the Initial Treatment of Metastatic Colorectal Cancer: a Multicentre Two-part Phase I/II Study BMC Cancer. 2009 | Pubmed ID: 19366444 Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival After Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2009 | Pubmed ID: 19318496 Association of Progression-free Survival, Overall Survival, and Patient-reported Outcomes by Skin Toxicity and KRAS Status in Patients Receiving Panitumumab Monotherapy Cancer. Apr, 2009 | Pubmed ID: 19189371 Vandetanib with FOLFIRI in Patients with Advanced Colorectal Adenocarcinoma: Results from an Open-label, Multicentre Phase I Study Cancer Chemotherapy and Pharmacology. Sep, 2009 | Pubmed ID: 19184020 Anti-epidermal Growth Factor Receptor Monotherapy in the Treatment of Metastatic Colorectal Cancer: Where Are We Today? The Oncologist. Jan, 2009 | Pubmed ID: 19144681 Expression of SGLT1, Bcl-2 and P53 in Primary Pancreatic Cancer Related to Survival Cancer Investigation. Oct, 2008 | Pubmed ID: 18853313 Clinical Usefulness of EGFR Gene Copy Number As a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab: a Fluorescent in Situ Hybridization Study Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2008 | Pubmed ID: 18794099 Unusual Serum Electrophoresis Pattern in a Woman with Pancreatic Carcinoma Clinical Chemistry. Sep, 2008 | Pubmed ID: 18755907 Microsatellite Instability in Sporadic Colon Carcinomas Has No Independent Prognostic Value in a Belgian Study Population European Journal of Cancer (Oxford, England : 1990). Oct, 2008 | Pubmed ID: 18707864 Wild-type KRAS is Required for Panitumumab Efficacy in Patients with Metastatic Colorectal Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Apr, 2008 | Pubmed ID: 18316791 Safety and Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with High-dose Oxaliplatin in Patients with Peritoneal Carcinomatosis Annals of Surgical Oncology. Feb, 2008 | Pubmed ID: 17960463 Is Combined 18F-fluorodeoxyglucose-positron Emission Tomography/computed Tomography Superior to Positron Emission Tomography or Computed Tomography Alone for Diagnosis, Staging and Restaging of Pancreatic Lesions? Acta Gastro-enterologica Belgica. Oct-Dec, 2007 | Pubmed ID: 18330088 Open-label Phase III Trial of Panitumumab Plus Best Supportive Care Compared with Best Supportive Care Alone in Patients with Chemotherapy-refractory Metastatic Colorectal Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2007 | Pubmed ID: 17470858 Imatinib for the Treatment of Patients with Unresectable or Metastatic Malignant KIT-positive Gastrointestinal Stromal Tumours: an Open-label Belgian Trial Acta Gastro-enterologica Belgica. Oct-Dec, 2006 | Pubmed ID: 17343077 Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis Maxim Le Compte1, Edgar Cardenas De La Hoz2, Sofía Peeters1, Evelien Smits1, Filip Lardon1, Geert Roeyen1,3, Steve Vanlanduit2, Hans Prenen1,4, Marc Peeters1,4, Abraham Lin1,5, Christophe Deben1 1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2Industrial Vision Lab, University of Antwerp, 3Department of Hepatobiliary Transplantation and Endocrine Surgery, University Hospital Antwerp (UZA), 4Department of Oncology, University Hospital Antwerp (UZA), 5Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp JoVE 64434 Ricerca sul cancro Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool Marco Giallombardo*1,2, Jorge Chacártegui Borrás*2,3, Marta Castiglia4, Nele Van Der Steen3, Inge Mertens5,6, Patrick Pauwels7,3, Marc Peeters8,3, Christian Rolfo2,3 1Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics, University of Palermo, 2Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA), 3Center for Oncological Research (CORE), Antwerp University, 4Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 5Flemish Institute for Technological Research (VITO), 6CORE, Campus Groenenborger, Antwerp University, 7Molecular Pathology, Pathology Department, Antwerp University Hospital (UZA), 8Oncology Department, Antwerp University Hospital (UZA) JoVE 53900 Medicina
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis Maxim Le Compte1, Edgar Cardenas De La Hoz2, Sofía Peeters1, Evelien Smits1, Filip Lardon1, Geert Roeyen1,3, Steve Vanlanduit2, Hans Prenen1,4, Marc Peeters1,4, Abraham Lin1,5, Christophe Deben1 1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2Industrial Vision Lab, University of Antwerp, 3Department of Hepatobiliary Transplantation and Endocrine Surgery, University Hospital Antwerp (UZA), 4Department of Oncology, University Hospital Antwerp (UZA), 5Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp JoVE 64434 Ricerca sul cancro
Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool Marco Giallombardo*1,2, Jorge Chacártegui Borrás*2,3, Marta Castiglia4, Nele Van Der Steen3, Inge Mertens5,6, Patrick Pauwels7,3, Marc Peeters8,3, Christian Rolfo2,3 1Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics, University of Palermo, 2Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA), 3Center for Oncological Research (CORE), Antwerp University, 4Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 5Flemish Institute for Technological Research (VITO), 6CORE, Campus Groenenborger, Antwerp University, 7Molecular Pathology, Pathology Department, Antwerp University Hospital (UZA), 8Oncology Department, Antwerp University Hospital (UZA) JoVE 53900 Medicina
